Table IV.
Donors | Age (months) |
Tissue | CD20-positive B cell subsets |
Number of sequences
|
Mutations
|
||||
---|---|---|---|---|---|---|---|---|---|
|
|
|
|
Total
|
Mutated
|
Range
|
Number
|
Frequency/ total sequences |
Frequency/ mutated sequences |
% | % | ||||||||
D3 | 8 | spleen | IgD+CD27+ | 21 | 10 (48%) |
0–6 | 23 | 0.32 | 0.67 |
IgD−CD27+ | 20 | 19 (95%) |
0–14 | 105 | 1.54 | 1.55 | |||
blood | IgD+CD27+ | 20 | 12 (60%) |
0–7 | 37 | 0.54 | 0.90 | ||
IgD−CD27+ | 18 | 13 (72%) |
0–16 | 103 | 1.67 | 2.32 | |||
D1 | 11 | blood | IgD+CD27+ | 20 | 15 (75%) |
0–17 | 79 | 1.16 | 1.54 |
IgD−CD27+ | 20 | 18 (90%) |
0–22 | 117 | 1.71 | 1.90 | |||
D2 | 11 | blood | IgD+CD27+ | 18 | 15 (83%) |
0–16 | 116 | 1.89 | 2.27 |
IgD−CD27+ | 17 | 16 (94%) |
0–21 | 127 | 2.19 | 2.32 | |||
D4 | 22 | spleen | IgD+CD27+ | 25 | 12 (48%) |
0–14 | 40 | 0.51 | 1.09 |
IgD−CD27+ | 14 | 13 (93%) |
0–23 | 91 | 1.90 | 2.05 |